Glenmark Sets Up Clinical R&D Unit At Oxford As Drug Pipeline Swells

MUMBAI - Glenmark Pharmaceuticals, one of India's fastest growing research-based drug companies, has set up a new clinical research and development outfit at Oxford Science and Business Park in the United Kingdom